Tag: Safety

FDA reduces N95 decontamination cycles from 20 to 4

Editor's Note The Food & Drug Administration (FDA), on January 22, lowered the number of times an N95 mask can be cleaned and reused to 4, down from a previous maximum of 20 reuses, the January 25 Fierce Biotec reports. The FDA reissued emergency use authorizations for 10 N95 decontamination…

Read More

By: Judy Mathias
January 28, 2021
Share

Survey finds 71% of employees concerned about vaccine side effects

Editor's Note A Welltok survey of 1,000 adults across the US finds that 71% of employees are worried about COVID-19 vaccine side effects, 60% of Americans have a vaccine brand preference, and 52% are worried about the vaccine supply, the January 25 Human Resource Executive reports. Employers, who are seen…

Read More

By: Judy Mathias
January 27, 2021
Share

FDA revises EUAs for N95 decontamination systems

Editor's Note The Food and Drug Administration on January 21 reissued emergency use authorizations (EUAs) for 10 systems used to decontaminate N95 respirators used by healthcare personnel . The 10 systems are: Michigan State University Decontamination System Technical Safety Services VHP Decontamination System Stryker Sustainability Solutions VHP Decontamination System STERIS…

Read More

By: Judy Mathias
January 26, 2021
Share

CDC: Anaphylactic reactions after first dose of Pfizer-BioNTech vaccine

Editor's Note From December 14 to 23, 2020, after administration of 1,893,360 first doses of the Pfizer-BioNTech COVID-19 vaccine, the Centers for Disease Control and Prevention (CDC) identified 21 case reports of anaphylaxis. Of those, 4 (19%) were hospitalized (including 3 in intensive care), and 17 (81%) were treated in…

Read More

By: Judy Mathias
January 25, 2021
Share

New negative-pressure ventilator to help treat COVID-19 patients

Editor's Note A new negative-pressure ventilatory support device, similar to the “iron lung” used to treat polio patients in the 1950s, provides an additional treatment option for COVID-19 patients, finds this study by researchers in the UK’s Exovent Task Force, formed in March 2020 in response to the COVID-19 pandemic.…

Read More

By: Judy Mathias
January 21, 2021
Share

AAMI releases four amendments to steam sterilization standard

Editor's Note The Association for Advancement of Medical Instrumentation (AAMI), on January 20, released four amendments to the “ANSI/AAMI ST79 Comprehensive guide to steam sterilization and sterility assurance in healthcare facilities.” Among the additions: recommendations and clarifications for maintaining the integrity of the sterile processing area, including common sense additions,…

Read More

By: Judy Mathias
January 21, 2021
Share

Study provides evidence that vaccines protect against new COVID-19 variants

Editor's Note A study, led by researchers from Rockefeller University in New York City, finds that volunteers vaccinated with either the Moderna or the Pfizer/BioNTech vaccine will be protected against new variants of the COVID-19 virus. The researchers tested plasma taken from 20 volunteers who had received both doses of…

Read More

By: Judy Mathias
January 21, 2021
Share

Joint Commission adds new performance measure for THKR certification

Editor's Note The Joint Commission, on January 20, announced that data collection for a new standardized performance measure assessing a patient’s functional and health status postoperatively will be required for the Advanced Certification for Total Hip and Total Knee Replacement (THKR) program. Organizations will be required to assess a patient’s…

Read More

By: Judy Mathias
January 21, 2021
Share

Willingness of US adults to get the COVID-19 vaccine

Editor's Note This study led by researchers from the Virginia Commonwealth University, Richmond, finds that COVID-19 vaccine-related messaging should address concerns about the vaccine and its development and reinforce its benefits to increase the willingness of US adults to get the COVID-19 vaccine and to get the vaccine under an…

Read More

By: Judy Mathias
January 20, 2021
Share

J&J’s single-dose COVID-19 vaccine has good safety profile

Editor's Note Results from Johnson & Johnson’s early-stage trials for its COVID-19 vaccine showed neutralizing antibodies in all participants who received the vaccine when they were tested at 57 days. The J&J Ad26.COV2.S vaccine is different than the Pfizer-BioNTech and Moderna vaccines in that it is anenovirus-based rather than mRNA-based.…

Read More

By: Judy Mathias
January 19, 2021
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat